Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Myositis
|
39 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||
White Blood Cell Count procedure
|
1003 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
130 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
130 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
130 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Basal Cell Cancer
|
109 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Basal cell carcinoma
|
109 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Basal Cell Neoplasm
|
109 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Blood basophil count (lab test)
|
452 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Cholangitis, Sclerosing
|
276 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Eosinophil count procedure
|
1133 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Granulocyte count
|
150 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Hodgkin Disease
|
41 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Lymphocyte Count measurement
|
199 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Neutrophil count (procedure)
|
234 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Ankylosing spondylitis
|
345 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.710 | 1.000 | 1 | 2016 | 2017 | ||||
Latent Autoimmune Diabetes in Adults
|
6 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.710 | 1.000 | 1 | 2018 | 2019 | ||||
Polymyositis
|
2 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.710 | 1.000 | 1 | 2008 | 2016 | ||||
Autoimmune thyroiditis
|
66 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.720 | 1.000 | 2 | 2006 | 2015 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
844 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.730 | 1.000 | 1 | 2008 | 2018 | ||||
Ulcerative Colitis
|
464 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.730 | 1.000 | 1 | 2011 | 2016 | ||||
Alopecia Areata
|
29 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.740 | 1.000 | 1 | 2006 | 2019 | ||||
Psoriasis
|
485 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.740 | 0.800 | 1 | 2008 | 2016 | ||||
Systemic Scleroderma
|
98 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.760 | 0.857 | 1 | 2006 | 2019 | ||||
Hypothyroidism
|
185 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.800 | 1.000 | 2 | 2012 | 2019 |